Utilization, Reimbursement, and Price of Incretin-Based and Peptides Therapies for Type 2 Diabetes in US Medicaid Program from 2005 to 2016
May 1, 2018, 00:00
10.1016/j.jval.2018.04.518
https://www.valueinhealthjournal.com/article/S1098-3015(18)30818-0/fulltext
Title :
Utilization, Reimbursement, and Price of Incretin-Based and Peptides Therapies for Type 2 Diabetes in US Medicaid Program from 2005 to 2016
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30818-0&doi=10.1016/j.jval.2018.04.518
First page :
Section Title :
Open access? :
No
Section Order :
1345